Market highlights for next week: Home Depot (HD), Macy's (M) to report
Posted Aug 10th 2007 4:15PM by Eric Buscemi
Filed under: Earnings reports, Conventions and conferences, Hewlett-Packard (HPQ), Home Depot (HD), Penney (J.C.) (JCP), QUALCOMM Inc (QCOM), Broadcom Corp'A' (BRCM)
.gif)
Monday August 13
Tuesday August 14
- The Home Depot Inc (NYSE: HD) to report Q2 earnings; conference call at 9am. Home Depot is expected to post substantial Q2 revenue/EPS declines, but equally important will be the company's comments: with the housing sector expected to remain sluggish through at least late 2007, analysts will evaluate whether HD can overcome that headwind with a new focus on customer service, demographic trends that suggest increased home repair/remodeling, and 20-year high homeownership rates that suggest steady house goods demand.
- District Court California: Broadcom Corporation (NASDAQ: BRCM) to request an injunction related to Qualcom Incorporated's (Nasdaq: QCOM) infringement of 3 Broadcom cellular baseband patents.
Wednesday August 15
- Macy's Inc (NYSE: M) to report Q2 earnings; conference call at 10:30am.
- PDUFA date for GPC Biotech's (NASDAQ: GPCB) Satraplatin for treatment of hormone refractory prostate cancer.
Thursday August 16
- JC Penney Co Inc (NYSE: JCP) to report Q2 earnings; conference call at 9:30am.
- Hewlett Packard Company (NYSE: HPQ) to report Q3 earnings; conference call at 5pm. Analysts will evaluate HPQ's ability to maintain momentum in its innovative imaging/printing group, which is expected to help HPQ post solid Q3 revenue gains.
Friday August 17
Tags: BRCM, Broadcom, conference, drug, earnings, Endo, Endo Pharmaceuticals, EndoPharmaceuticals, ENDP, Frova, GPC Biotech, GPCB, GpcBiotech, HD, Hewlett Packard, HewlettPackard, Home Depot, HomeDepot, HPQ, IDEV, Indevus, infringement, J.C. Penney, J.c.Penney, JC Penney, JCP, JcPenney, lawsuit, M, Macy's, patent, QCOM, QTM, Qualcomm, Quantum, Sanctura XR, SancturaXr, Satraplatin, Sysco, SYY, Vernalis, VNLSY